423.9000 -2.20 (-0.52%)
NSE Aug 11, 2026 14:12 PM
Volume: 1.6M
 

logo
Biocon Ltd.
12 Nov 2024
423.90
-0.52%
Sharekhan
Revenues stood at Rs. 3,590 crore, up 4% y-o-y and a 5% rise q-o-q. EBITDA reached Rs. 730 crore, down 1% y-o-y but up 24% q-o-q. PAT stood at Rs. 27 crore, a decline of 84% y-o-y and 97% q-o-q.
Motilal Oswal increased Buy price target of Biocon Ltd. to 520.0 on 06 Aug, 2026.
More from Biocon Ltd.
Recommended